Get the Stockscreener App
48.44
1.90%
-0.94
After Hours:
48.44
Azenta Inc stock is traded at $48.44, with a volume of 555.39K.
It is down -1.90% in the last 24 hours and down -2.18% over the past month.
Azenta Inc is a provider of life sciences solutions, enabling impactful breakthroughs and therapies to market faster. It provides a full suite of reliable cold-chain sample management solutions and genomic services across areas such as drug development, clinical research and advanced cell therapies for the industry's top pharmaceutical, biotech, academic and healthcare institutions globally. The company has two reportable segments that are Life Sciences Products and Life Sciences Services. It generates a substantial part of its revenue from its Life Sciences Services segment.
See More
Previous Close:
$49.38
Open:
$49.13
24h Volume:
555.39K
Relative Volume:
0.96
Market Cap:
$2.42B
Revenue:
$658.62M
Net Income/Loss:
$-155.81M
P/E Ratio:
-93.15
EPS:
-0.52
Net Cash Flow:
$40.93M
1W Performance:
-1.32%
1M Performance:
-2.18%
6M Performance:
-19.64%
1Y Performance:
-3.49%
1-Day Range:
$47.98
$49.55
1-Week Range:
$46.63
$50.33
52-Week Range:
$44.00
$69.16
Azenta Inc Stock (AZTA) Company Profile
Name
Azenta Inc
Sector
Industry
Phone
(978) 262-2400
Address
200 SUMMIT DRIVE, BURLINGTON
Azenta Inc Stock (AZTA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-01-24 | Reiterated | B. Riley Securities | Buy |
| Jul-19-23 | Initiated | Raymond James | Mkt Perform |
| May-10-23 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Feb-09-23 | Downgrade | Stephens | Overweight → Equal-Weight |
| Jan-03-23 | Downgrade | Evercore ISI | Outperform → In-line |
| Mar-31-22 | Resumed | B. Riley Securities | Buy |
| Mar-21-22 | Initiated | Evercore ISI | Outperform |
View All
Azenta Inc Stock (AZTA) Latest News
Short Interest in Azenta, Inc. (NASDAQ:AZTA) Expands By 5.3% - MarketBeat
Azenta Selected To Provide Comprehensive Proteomic Profiling for Population Scale Personalized Medicine Project - Technology Networks
Systematic Financial Management LP Sells 21,277 Shares of Azenta, Inc. (NASDAQ:AZTA) - MarketBeat
American Century Companies Inc. Buys 27,882 Shares of Azenta, Inc. (NASDAQ:AZTA) - MarketBeat
Financial Metrics Exploration: Understanding Azenta Inc (AZTA) Through Ratios - The Dwinnex
Envestnet Asset Management Inc. Sells 66,651 Shares of Azenta, Inc. (NASDAQ:AZTA) - MarketBeat
Kayne Anderson Rudnick Investment Management LLC Increases Stake in Azenta, Inc. (NASDAQ:AZTA) - MarketBeat
AstraZeneca PLC (NASDAQ:AZN) Stock Position Increased by Callan Capital LLC - Defense World
Is Azenta Inc (AZTA) worth investing in despite its overvalued state? - US Post News
AstraZeneca (LSE:AZN) Gains FDA Approval for Fasenra in EGPA, Boosting Revenue Growth and Market Position - Yahoo Finance UK
Rhumbline Advisers Lowers Stake in AstraZeneca PLC (NASDAQ:AZN) - Defense World
IBD Rating Upgrades: AZEK Shows Improved Technical Strength - Investor's Business Daily
AstraZeneca India to launch Palivizumab in Oct 2024, stocks trade flat - BusinessLine
Vanguard Personalized Indexing Management LLC Increases Stake in AstraZeneca PLC (NASDAQ:AZN) - Defense World
AstraZeneca PLC (NASDAQ:AZN) Shares Bought by Hsbc Holdings PLC - Defense World
Axxcess Wealth Management LLC Cuts Holdings in AstraZeneca PLC (NASDAQ:AZN) - Defense World
Victory Capital Management Inc. Increases Position in AZZ Inc. (NYSE:AZZ) - Defense World
Could The Market Be Wrong About AstraZeneca PLC (LON:AZN) Given Its Attractive Financial Prospects? - Yahoo Finance
AZTR’s Market Fluctuations: Is Now the Right Time to Invest? - The InvestChronicle
Should you buy shares in AstraZeneca? Today’s options explained - The Times
Investing in Astrazeneca plc ADR (AZN) Is Getting More Attractive - Knox Daily
Zurich Insurance raised to Aa2 by Moody's on strong, stable earnings (OTCQX:ZURVY) - Seeking Alpha
AZN Gets FDA Nod for Fasenra Label Expansion in Rare Disease - Zacks Investment Research
Prepare Yourself for Liftoff: Azenta Inc (AZTA) - SETE News
Analyzing the Impact of Earnings Reports on Astrazeneca plc ADR Inc. (AZN) Price Performance - The InvestChronicle
Arzeda Raises $38M Funding - citybiz
AstraZeneca PLC (NASDAQ:AZN) Receives Consensus Recommendation of "Moderate Buy" from Analysts - MarketBeat
AstraZeneca PLC (NASDAQ:AZN) Given Consensus Recommendation of “Moderate Buy” by Analysts - Defense World
AstraZeneca’s Fasenra Wins FDA Approval for Rare Vasculitis - TipRanks
Where are the Opportunities in (AZN) - Stock Traders Daily
AstraZeneca PLC ADR outperforms competitors despite losses on the day - MarketWatch
Meeder Advisory Services Inc. Makes New Investment in AstraZeneca PLC (NASDAQ:AZN) - Defense World
William Blair Investment Management LLC Sells 17,390 Shares of AstraZeneca PLC (NASDAQ:AZN) - Defense World
Azenta, Inc. (NASDAQ:AZTA) Short Interest Up 5.4% in August - MarketBeat
Federated Hermes Inc. Increases Position in AZZ Inc. (NYSE:AZZ) - Defense World
AstraZeneca’s (AZN) “Overweight” Rating Reaffirmed at JPMorgan Chase & Co. - Defense World
Azenta Announces New Biorepository in the Greater Boston Area - GuruFocus.com
AstraZeneca PLC ADR rises Monday, outperforms market - MarketWatch
JPMorgan Chase & Co. Reaffirms Overweight Rating for AstraZeneca (LON:AZN) - MarketBeat
AZN January 2027 Options Begin Trading - Nasdaq
Market Momentum: Astrazeneca plc ADR (AZN) Registers a -0.87 Decrease, Closing at 78.27 - The Dwinnex
LPL Financial LLC Raises Position in AstraZeneca PLC (NASDAQ:AZN) - Defense World
Federated Hermes Inc. Has $22.76 Million Stock Holdings in Azenta, Inc. (NASDAQ:AZTA) - MarketBeat
Arizona State Retirement System Has $597,000 Holdings in AZZ Inc. (NYSE:AZZ) - Defense World
AstraZeneca Cut to Sell as Analyst Sees Challenging Risk/Reward - AskTraders
Johnson Investment Counsel Inc. Has $557,000 Stock Holdings in AstraZeneca PLC (NASDAQ:AZN) - Defense World
AstraZeneca (NASDAQ:AZN) Rating Lowered to Sell at Deutsche Bank Aktiengesellschaft - Defense World
Prudential PLC Increases Stake in AstraZeneca PLC (NASDAQ:AZN) - Defense World
Daiwa Securities Group Inc. Boosts Position in AstraZeneca PLC (NASDAQ:AZN) - Defense World
Rhumbline Advisers Boosts Stock Position in AZZ Inc. (NYSE:AZZ) - Defense World
Gaining Ground: Azenta Inc (AZTA) Closes Higher at 46.09, Up 0.55 - The Dwinnex
Azenta Inc Stock (AZTA) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.15%
0.19%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):